
PMC:7352545 / 23215-24578
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T79 | 16-18 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | SA |
T80 | 313-319 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
T81 | 641-643 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | SA |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T215 | 538-548 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T216 | 888-896 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T89 | 407-416 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T90 | 702-711 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T91 | 830-862 | Disease | denotes | human parainfluenza virus type 3 | http://purl.obolibrary.org/obo/MONDO_0042974 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T285 | 131-133 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T286 | 282-285 | http://purl.obolibrary.org/obo/CLO_0051568 | denotes | SAs |
T287 | 307-309 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T288 | 340-341 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T289 | 417-418 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T290 | 423-424 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T291 | 425-432 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T292 | 507-509 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T293 | 572-578 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T294 | 617-619 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T295 | 623-625 | http://purl.obolibrary.org/obo/CLO_0002105 | denotes | C2 |
T296 | 623-625 | http://purl.obolibrary.org/obo/CLO_0051742 | denotes | C2 |
T297 | 665-673 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T298 | 712-713 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T299 | 714-719 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T300 | 741-742 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T301 | 743-748 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T302 | 759-762 | http://purl.obolibrary.org/obo/CLO_0054060 | denotes | 102 |
T303 | 830-835 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T304 | 850-855 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T305 | 870-873 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T306 | 874-876 | http://purl.obolibrary.org/obo/CLO_0003788 | denotes | HN |
T307 | 907-909 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T308 | 1005-1008 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T309 | 1009-1010 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T310 | 1029-1030 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T311 | 1116-1118 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T312 | 1285-1287 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T591 | 16-18 | Chemical | denotes | SA | http://purl.obolibrary.org/obo/CHEBI_35962|http://purl.obolibrary.org/obo/CHEBI_38358|http://purl.obolibrary.org/obo/CHEBI_45373|http://purl.obolibrary.org/obo/CHEBI_74801|http://purl.obolibrary.org/obo/CHEBI_26667 |
T596 | 136-138 | Chemical | denotes | Ac | http://purl.obolibrary.org/obo/CHEBI_33337|http://purl.obolibrary.org/obo/CHEBI_40574 |
T598 | 166-168 | Chemical | denotes | Ac | http://purl.obolibrary.org/obo/CHEBI_33337|http://purl.obolibrary.org/obo/CHEBI_40574 |
T600 | 184-186 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T601 | 187-197 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T602 | 256-258 | Chemical | denotes | Ac | http://purl.obolibrary.org/obo/CHEBI_33337|http://purl.obolibrary.org/obo/CHEBI_40574 |
T604 | 276-278 | Chemical | denotes | Ac | http://purl.obolibrary.org/obo/CHEBI_33337|http://purl.obolibrary.org/obo/CHEBI_40574 |
T606 | 313-319 | Chemical | denotes | Neu5Ac | http://purl.obolibrary.org/obo/CHEBI_17012|http://purl.obolibrary.org/obo/CHEBI_75133 |
T608 | 393-403 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T609 | 492-494 | Chemical | denotes | Ac | http://purl.obolibrary.org/obo/CHEBI_33337|http://purl.obolibrary.org/obo/CHEBI_40574 |
T611 | 495-500 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T612 | 538-548 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T613 | 538-543 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T614 | 544-548 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T615 | 549-552 | Chemical | denotes | Glu | http://purl.obolibrary.org/obo/CHEBI_16015|http://purl.obolibrary.org/obo/CHEBI_18237|http://purl.obolibrary.org/obo/CHEBI_29972 |
T618 | 623-625 | Chemical | denotes | C2 | http://purl.obolibrary.org/obo/CHEBI_30083 |
T619 | 641-643 | Chemical | denotes | SA | http://purl.obolibrary.org/obo/CHEBI_35962|http://purl.obolibrary.org/obo/CHEBI_38358|http://purl.obolibrary.org/obo/CHEBI_45373|http://purl.obolibrary.org/obo/CHEBI_74801|http://purl.obolibrary.org/obo/CHEBI_26667 |
T624 | 888-896 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T625 | 942-954 | Chemical | denotes | alkyl groups | http://purl.obolibrary.org/obo/CHEBI_22323 |
T626 | 969-980 | Chemical | denotes | ethyl group | http://purl.obolibrary.org/obo/CHEBI_37807 |
T627 | 969-974 | Chemical | denotes | ethyl | http://purl.obolibrary.org/obo/CHEBI_62801 |
T628 | 975-980 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T629 | 1033-1048 | Chemical | denotes | guanidino group | http://purl.obolibrary.org/obo/CHEBI_48551 |
T630 | 1043-1048 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T631 | 1153-1164 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T632 | 1184-1191 | Chemical | denotes | Tamiflu | http://purl.obolibrary.org/obo/CHEBI_7798|http://purl.obolibrary.org/obo/CHEBI_7799 |
T634 | 1217-1226 | Chemical | denotes | zanamivir | http://purl.obolibrary.org/obo/CHEBI_50663 |
T635 | 1246-1253 | Chemical | denotes | Relenza | http://purl.obolibrary.org/obo/CHEBI_50663 |
T636 | 1296-1301 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T221 | 0-139 | Sentence | denotes | The position of SA O-acetylation is linked to functions including substrate differentiation of enzymes such as NAs and esterase by C4 O-Ac. |
T222 | 140-269 | Sentence | denotes | Previous development of O-Ac site-selective NA inhibitors were based on the conceptual consideration of different O-Ac positions. |
T223 | 270-378 | Sentence | denotes | The O-Ac of SAs is site-specific, as C4 of Neu5Ac is considered to be a potential position for modification. |
T224 | 379-487 | Sentence | denotes | Historically, inhibitors of influenza A and B viruses-sialidases were designed by Von-Itzstein in 1993 [39]. |
T225 | 488-597 | Sentence | denotes | The Ac group-based C4 substitution interacts with amino acid Glu-119 present in the active site of sialidase. |
T226 | 598-767 | Sentence | denotes | Guanidine-attached C4 of C2–C3 unsaturated SA (Neu5Ac2en) inhibits activity of sialidases isolated from influenza A virus (Singapore/1/57) and B virus (Victoria/102/85). |
T227 | 768-902 | Sentence | denotes | The same scenario was applied for sialidase inhibition of the human parainfluenza virus type 3, which has HN and fusion proteins [40]. |
T228 | 903-981 | Sentence | denotes | The C4 of Neu5Ac2en was substituted by alkyl groups such as the O-ethyl group. |
T229 | 982-1071 | Sentence | denotes | For example, Zanamivir has a substitution with a 4-guanidino group with an IC50 of 25 μM. |
T230 | 1072-1145 | Sentence | denotes | Thus, sialidase inhibition is important for C4 modification of Neu5Ac2en. |
T231 | 1146-1289 | Sentence | denotes | Later, oseltamivir with the tradename Tamiflu (Basel, Switzerland) and zanamivir with the tradename Relenza (London, UK) were established [41]. |
T232 | 1290-1363 | Sentence | denotes | These drugs exhibit some adverse side effects that restrict clinical use. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32604730-8502295-51943981 | 483-485 | 8502295 | denotes | 39 |
32604730-17236768-51943982 | 898-900 | 17236768 | denotes | 40 |
32604730-19770846-51943983 | 1285-1287 | 19770846 | denotes | 41 |
T21609 | 483-485 | 8502295 | denotes | 39 |
T5112 | 898-900 | 17236768 | denotes | 40 |
T69375 | 1285-1287 | 19770846 | denotes | 41 |